Author:
Daiber Andreas,Oelze Matthias,Coldewey Meike,Kaiser K.,Huth C.,Schildknecht S.,Bachschmid M.,Nazirisadeh Y.,Ullrich V.,Mülsch A.,Münzel T.,Tsilimingas N.
Subject
Cell Biology,Molecular Biology,Biochemistry,Biophysics
Reference36 articles.
1. Effect of vasodilator therapy on mortality in chronic congestive heart failure. Results of a Veterans Administration Cooperative Study;Cohn;N. Engl. J. Med.,1986
2. Combined oral hydralazine-nitrate therapy in left ventricular failure. Hemodynamic equivalency to sodium nitroprusside;Pierpont;Chest,1978
3. Effect of vasodilator therapy on mortality in chronic congestive heart failure;Cohn;Eur. Heart J.,1988
4. Ejection fraction, peak exercise oxygen consumption, cardiothoracic ratio, ventricular arrhythmias, and plasma norepinephrine as determinants of prognosis in heart failure. The V-HeFT VA Cooperative Studies Group;Cohn;Circulation,1993
5. The vasodilator-heart failure trials (V-HeFT). Mechanistic data from the VA cooperative studies. Introduction;Cohn;Circulation,1993
Cited by
106 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献